Wall Street's major averages finished in the red on Friday as technology stocks continued to lag amid artificial intelligence spending fears and a continued rise in oil prices due to geopolitical ...

The company’s stock dropped after details of a study raised questions about how widely the treatment would be used.

Moderna released full data on its closely watched cancer vaccine developed with Merck.

Six melanoma specialists said the Moderna and Merck vaccine results represent a clinically meaningful advance in melanoma ...

The drop is a sharp reversal of a massive 2026 stock rally fueled by optimism over its personalized cancer vaccine.

Details from a closely guarded study were to be released at a conference on Saturday.

Moderna shares are taking a hit after the leak of highly anticipated details about the company’s vaccine for the skin cancer ...

The results, which triggered Moderna’s stock to drop, are “really encouraging,” says Karen Knudsen, CEO of the Parker ...

So, right now, is Moderna a buy on the dip? It's important to keep in mind that the stock still has climbed more than 500% ...

CAMBRIDGE, MA / ACCESS Newswire / October 23, 2026 / (NASDAQ:MRNA) today announced it was ranked as a top employer in the ...

Severe sunburn increases the risk of developing melanoma, the most serious type of skin cancer. Credit: Olga Pankova/Getty. A ...

Can AI help us fight cancer more effectively? Moderna is putting that promise to the test, using AI to help design ...